Lorin J. Randall - 10 Jun 2022 Form 4 Insider Report for ACORDA THERAPEUTICS INC

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 10 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jun 2022, 08:19:50 UTC
Prior SEC filing: 15 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Lorin J. Randall

Key filing fact

Lorin J. Randall filed Form 4 for ACORDA THERAPEUTICS INC on 14 Jun 2022.

Key facts

This page summarizes Lorin J. Randall's Form 4 filing for ACORDA THERAPEUTICS INC.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Jun 2022, 08:19.

Change

Previous filing in this sequence was filed on 15 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACOR transaction Derivative

Non-Employee Stock Option

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 10 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $0.3699
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to this option vest in four equal quarterly installments over 12 months beginning on June 10, 2022, with the first quarterly installment vesting on September 10, 2022.